Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07605052 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight

Name: A Research Study to Compare Blood Levels of Two Different Versions of Cagrilintide in Adults With Excess Body Weight — clinical trial record (NCT07605052)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusCompleted

PhasePhase 1

SponsorNovo Nordisk A/S

Started2026-05-20

View on ClinicalTrials.gov ↗

The purpose of this clinical study is to compare 2 different versions cagrilintide and see how these work in people living with excess body weight. Participant will get either cagrilintide B or cagrilintide D injections. Which treatment participant will get is decided by chance. Participant will be in this clinical study for about 14 weeks.

Amendment history 2 changes detected by DataLookout

2026-09-05

Trial completed

2026-07-10

Trial status changed: Not Yet Recruiting → Active, Not Recruiting

Trial Details

NCT Number	NCT07605052
Lead Sponsor	Novo Nordisk A/S
Conditions	Overweight, Obesity
Enrollment	50 participants
Start Date	2026-05-20
Primary Completion	2026-08-19 (estimated)
Study Completion	2026-08-19 (estimated)
Updated on ClinicalTrials.gov	2026-09-04